QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.103.057257v1 308/2/712    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shaqura, M. A. Articles by Schäfer, M. Search for Related Content PubMed PubMed Citation Articles by Shaqura, M. A. Articles by Schäfer, M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Pain

NEUROPHARMACOLOGY

Characterization of µ Opioid Receptor Binding and G Protein Coupling in Rat Hypothalamus, Spinal Cord, and Primary Afferent Neurons during Inflammatory Pain

Klinik für Anaesthesiologie und operative Intensivmedizin, Charité, Universitätsmedizin Berlin Campus Benjamin Franklin, Berlin, Germany

Peripheral analgesic effects of opioids are pronounced under inflammatory conditions, e.g., arthritis; however, little is known about adaptive changes of µ opioid receptor binding and G protein coupling in the peripheral versus central nervous system. The present study investigated the effects of inflammation on µ opioid receptor (MOP receptor) binding and G protein coupling of supraspinal, spinal, and peripheral MOP receptors. In addition, MOP receptors were identified in immunohistochemical experiments in dorsal root ganglia (DRG) of inflamed and noninflamed rats. The number of MOP receptor binding sites decreased from hypothalamus (HT) > spinal cord (SC) > DRG. Unilateral Freund's complete adjuvant inflammation of one hindpaw induced a significant up-regulation of MOP receptor sites only in DRG but not in HT or SC. This up-regulation was time-dependent, restricted to the inflamed side, and showed a peak at 24 h. The full-agonist [D-Ala²,N-MePhe⁴,Gly⁵-ol]-enkephalin (DAMGO) induced MOP receptor G protein coupling with decreasing efficacies (E_max) from HT > SC > DRG. Inflammation resulted in significant increases in MOP receptor G protein coupling only in membranes of DRG, but not in HT, SC, or DRG on the contralateral side of inflammation. This suggests that changes in MOP receptor levels are not related to systemically released mediators. These findings show that inflammation causes changes in MOP receptor binding and G protein coupling after DAMGO stimulation selectively in primary afferent neurons but did not cause any adaptive changes of MOP receptor in HT or SC.

Address correspondence to: Dr. Christian Zöllner, Klinik für Anaesthesiologie und operative Intensivmedizin, Charité Universitätsmedizin Berlin Campus Benjamin Franklin, Hindenburgdamm 30, 12200 Berlin. E-mail: christian.zoellner{at}charite.de

This article has been cited by other articles:

				K. T. Sykes, S. R. White, R. W. Hurley, H. Mizoguchi, L. F. Tseng, and D. L. Hammond Mechanisms Responsible for the Enhanced Antinociceptive Effects of {micro}-Opioid Receptor Agonists in the Rostral Ventromedial Medulla of Male Rats with Persistent Inflammatory Pain J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 813 - 821. [Abstract] [Full Text] [PDF]

				S. A. Mousa, B. P. Cheppudira, M. Shaqura, O. Fischer, J. Hofmann, R. Hellweg, and M. Schafer Nerve growth factor governs the enhanced ability of opioids to suppress inflammatory pain Brain, February 1, 2007; 130(2): 502 - 513. [Abstract] [Full Text] [PDF]

				X. Wang, R. J. Traub, and A. Z. Murphy Persistent pain model reveals sex difference in morphine potency Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2006; 291(2): R300 - R306. [Abstract] [Full Text] [PDF]

				H. N. Wenk, J.-D. Brederson, and C. N. Honda Morphine Directly Inhibits Nociceptors in Inflamed Skin J Neurophysiol, April 1, 2006; 95(4): 2083 - 2097. [Abstract] [Full Text] [PDF]

				I. Bileviciute-Ljungar, M. Spetea, Y. Guo, J. Schutz, P. Windisch, and H. Schmidhammer Peripherally Mediated Antinociception of the {micro}-Opioid Receptor Agonist 2-[(4,5{alpha}-Epoxy-3-hydroxy-14beta-methoxy-17-methylmorphinan-6beta-yl)amino]acetic Acid (HS-731) after Subcutaneous and Oral Administration in Rats with Carrageenan-Induced Hindpaw Inflammation J. Pharmacol. Exp. Ther., April 1, 2006; 317(1): 220 - 227. [Abstract] [Full Text] [PDF]

				D. Wang, X. Sun, L. M. Bohn, and W. Sadee Opioid Receptor Homo- and Heterodimerization in Living Cells by Quantitative Bioluminescence Resonance Energy Transfer Mol. Pharmacol., June 1, 2005; 67(6): 2173 - 2184. [Abstract] [Full Text] [PDF]

				J. P. Williams and D. G. Lambert Editorial II: Opioids and the neuroimmune axis Br. J. Anaesth., January 1, 2005; 94(1): 3 - 6. [Full Text] [PDF]

				R. Likar, S. A. Mousa, G. Philippitsch, H. Steinkellner, W. Koppert, C. Stein, and M. Schafer Increased numbers of opioid expressing inflammatory cells do not affect intra-articular morphine analgesia Br. J. Anaesth., September 1, 2004; 93(3): 375 - 380. [Abstract] [Full Text] [PDF]